Casdin Capital sold 380,000 shares of Structure Therapeutics in the fourth quarter for an estimated $15.52 million. Meanwhile, the quarter-end position value actually increased by $38.18 million, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results